Corporate report

MHRA Corporate Plan 2018 to 2023

This plan outlines the Agency’s strategic direction over the next five years, including how we ensure a smooth EU exit under any scenario.


Medicines and Healthcare Products Regulatory Agency: corporate plan, 2018 to 2023

This file may not be suitable for users of assistive technology. Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email Please tell us what format you need. It will help us if you say what assistive technology you use.


Contents include the priority actions and activities which the Agency will take forward to ensure delivery of the statutory role and functions of the Agency.

Published 24 April 2018